Search Results - "Langton, E. E."

Refine Results
  1. 1

    Absence of effects of widespread badger culling on tuberculosis in cattle by Torgerson, Paul R., Hartnack, Sonja, Rasmussen, Philip, Lewis, Fraser, Langton, Thomas E. S.

    Published in Scientific reports (15-07-2024)
    “…Government policy in England aims for the elimination of bovine tuberculosis (bTB). This policy includes culling of European badger ( Meles meles ) to reduce…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Perfluorochemicals and human semen quality: the LIFE study by Louis, Germaine M Buck, Chen, Zhen, Schisterman, Enrique F, Kim, Sungduk, Sweeney, Anne M, Sundaram, Rajeshwari, Lynch, Courtney D, Gore-Langton, Robert E, Barr, Dana Boyd

    Published in Environmental health perspectives (01-01-2015)
    “…The relation between persistent environmental chemicals and semen quality is evolving, although limited data exist for men recruited from general populations…”
    Get full text
    Journal Article
  4. 4

    Conception by fertility treatment and cardiometabolic risk in middle childhood by Yeung, Edwina H, Mendola, Pauline, Sundaram, Rajeshwari, Lin, Tzu-Chun, Broadney, Miranda M, Putnick, Diane L, Robinson, Sonia L, Polinski, Kristen J, Wactawski-Wende, Jean, Ghassabian, Akhgar, O'Connor, Thomas G, Gore-Langton, Robert E, Stern, Judy E, Bell, Erin

    Published in Fertility and sterility (01-08-2022)
    “…To evaluate whether children conceived using assisted reproductive technology (ART) or ovulation induction (OI) have greater cardiometabolic risk than children…”
    Get full text
    Journal Article
  5. 5

    Persistent organic pollutants and semen quality: The LIFE Study by Mumford, Sunni L., Kim, Sungduk, Chen, Zhen, Gore-Langton, Robert E., Boyd Barr, Dana, Buck Louis, Germaine M.

    Published in Chemosphere (Oxford) (01-09-2015)
    “…•Chemicals in each of four classes of POPs associated with semen quality.•Associations indicate both positive and negative effects on semen quality.•POPs at…”
    Get full text
    Journal Article
  6. 6

    Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: An update by Frei, D., Stowell, K. M., Langton, E. E., McRedmond, L., Pollock, N. A., Bulger, T. F.

    Published in Anaesthesia and intensive care (01-09-2017)
    “…Testing for malignant hyperthermia in New Zealand involves two tests-in vitro contracture testing of excised lateral quadriceps muscle and DNA analysis. In…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Common data elements for substance use disorders in electronic health records: the NIDA Clinical Trials Network experience by Ghitza, Udi E., Gore-Langton, Robert E., Lindblad, Robert, Shide, David, Subramaniam, Geetha, Tai, Betty

    Published in Addiction (Abingdon, England) (01-01-2013)
    “…ABSTRACT Aims  Electronic health records (EHRs) are essential in improving quality and enhancing efficiency of health‐care delivery. By 2015, medical care…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus by Rush, A John, Gore-Langton, Robert E, Bart, Gavin, Bradley, Katharine A, Campbell, Cynthia I, McKay, James, Oslin, David W, Saxon, Andrew J, Winhusen, T John, Wu, Li-Tzy, Moran, Landhing M, Tai, Betty

    Published in Addiction science & clinical practice (28-02-2024)
    “…The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available…”
    Get full text
    Journal Article
  12. 12

    Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibilityidentified: Missed opportunities prior to diagnosis by TY Chan, TF Bulger, KM Stowell, RL Gillies, EE Langton, NE Street, NA Pollock

    Published in Anaesthesia and intensive care (01-11-2017)
    “…Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered almost exclusively by potent inhalational agents and suxamethonium. Signs…”
    Get full text
    Journal Article
  13. 13

    Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report by Bart, Gavin B, Saxon, Andrew, Fiellin, David A, McNeely, Jennifer, Muench, John P, Shanahan, Christopher W, Huntley, Kristen, Gore-Langton, Robert E

    Published in Addiction science & clinical practice (16-01-2020)
    “…There is an urgent need for strategies to address the US epidemic of prescription opioid, heroin and fentanyl-related overdoses, misuse, addiction, and…”
    Get full text
    Journal Article
  14. 14

    Estimation of myocardial strain from non-rigid registration and highly accelerated cine CMR by Langton, Jonathan E. N., Lam, Hoi-Ieng, Cowan, Brett R., Occleshaw, Christopher J., Gabriel, Ruvin, Lowe, Boris, Lydiard, Suzanne, Greiser, Andreas, Schmidt, Michaela, Young, Alistair A.

    “…Sparsely sampled cardiac cine accelerated acquisitions show promise for faster evaluation of left-ventricular function. Myocardial strain estimation using…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update by Barnes, C, Stowell, K M, Bulger, T, Langton, E, Pollock, N

    Published in Anaesthesia and intensive care (01-01-2015)
    “…The postoperative care of malignant hyperthermia (MH) patients is subject to international variation, with a paucity of data in the literature to guide…”
    Get full text
    Journal Article
  17. 17

    Evidence of Malignant Hyperthermia in Patients Administered Triggering Agents before Malignant Hyperthermia Susceptibility Identified: Missed Opportunities Prior to Diagnosis by Chan, T. Y., Bulger, T. F., Stowell, K. M., Gillies, R. L., Langton, E. E., Street, N. E., Pollock, N. A.

    Published in Anaesthesia and intensive care (01-11-2017)
    “…Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered almost exclusively by potent inhalational agents and suxamethonium. Signs…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents by POLLOCK, N, LANGTON, E. E, STOWELL, K. M, BULGER, T. F

    Published in Anaesthesia and intensive care (01-09-2011)
    “…As the reliability of malignant hyperthermia normal in vitro contracture test results has been questioned, this study set out to determine the reliability of…”
    Get full text
    Journal Article